Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars
出版年份 2017 全文链接
标题
Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars
作者
关键词
-
出版物
Targeted Oncology
Volume 12, Issue 5, Pages 599-610
出版商
Springer Nature
发表日期
2017-08-11
DOI
10.1007/s11523-017-0518-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry
- (2016) Yoko Tomita et al. ACTA ONCOLOGICA
- Statistical Primer on Biosimilar Clinical Development
- (2016) Leah Isakov et al. AMERICAN JOURNAL OF THERAPEUTICS
- Secondary efficacy results from a phase 3 study comparing efficacy and safety of biosimilar candidate ABP 215 with bevacizumab in patients with non-squamous non-small cell lung cancer (NSCLC)
- (2016) N. Thatcher et al. ANNALS OF ONCOLOGY
- ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe
- (2016) N. Cherny et al. ANNALS OF ONCOLOGY
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis
- (2016) Tobias Engel Ayer Botrel et al. BMC CANCER
- Population pharmacokinetics of bevacizumab in cancer patients with external validation
- (2016) Kelong Han et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers
- (2016) Beverly Knight et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A clinician’s guide to biosimilars in oncology
- (2016) Hope S. Rugo et al. CANCER TREATMENT REVIEWS
- Patterns of Biologics Use Across Treatment Lines in Elderly (Age >65) Medicare Patients With Metastatic Colon Cancer
- (2016) Kaloyan A. Bikov et al. ONCOLOGIST
- Clinical safety of tbo-filgrastim, a short-acting human granulocyte colony-stimulating factor
- (2016) Ruth Pettengell et al. SUPPORTIVE CARE IN CANCER
- Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial
- (2015) A. Passardi et al. ANNALS OF ONCOLOGY
- Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
- (2015) G. Masi et al. ANNALS OF ONCOLOGY
- Maintenance therapy for metastatic colorectal cancer
- (2015) Fortunato Ciardiello LANCET ONCOLOGY
- After counterfeit Avastin®—what have we learned and what can be done?
- (2015) Tim K. Mackey et al. Nature Reviews Clinical Oncology
- The economics of counterfeit Avastin: a geospatial and statistical analysis of demographic correlates to FDA warning letters
- (2015) Raphael E. Cuomo et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Value of bevacizumab in treatment of colorectal cancer: A meta-analysis
- (2015) Chun-Ying Qu WORLD JOURNAL OF GASTROENTEROLOGY
- Development of biosimilars in an era of oncologic drug shortages
- (2015) Edward Li et al. Drug Design Development and Therapy
- Selection of biologics for patients with metastatic colorectal cancer: the role of predictive markers
- (2015) Pashtoon Murtaza Kasi et al. Expert Review of Gastroenterology & Hepatology
- Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- The challenge of indication extrapolation for infliximab biosimilars
- (2014) Brian G. Feagan et al. BIOLOGICALS
- Biosimilars: the science of extrapolation
- (2014) M. Weise et al. BLOOD
- Does the cancer drugs fund lead to faster uptake of cost-effective drugs? A time-trend analysis comparing England and Wales
- (2014) C Chamberlain et al. BRITISH JOURNAL OF CANCER
- Colorectal cancer
- (2013) Hermann Brenner et al. LANCET
- Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial
- (2013) David Cunningham et al. LANCET ONCOLOGY
- Clinical experience with Zarzio® in Europe: what have we learned?
- (2013) Pere Gascón et al. SUPPORTIVE CARE IN CANCER
- Bevacizumab in elderly patients with metastatic colorectal cancer
- (2013) Francesco Sclafani et al. Journal of Geriatric Oncology
- Hospital Management of Outpatient Oncology Treatment Decisions: A Survey to Identify Strategies and Concerns
- (2013) Edward Li et al. Journal of Oncology Practice
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
- (2012) Jaafar Bennouna et al. LANCET ONCOLOGY
- Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer
- (2012) J. H. Strickler et al. ONCOLOGIST
- Bevacizumab for Metastatic Colorectal Cancer
- (2012) Sophie Whyte et al. PHARMACOECONOMICS
- Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial
- (2012) Zhong-Zhen Guan et al. Chinese Journal of Cancer
- Less Than Ideal: How Oncologists Practice With Limited Drug Access
- (2012) Kelvin K. Chan et al. Journal of Oncology Practice
- Survival for Metastatic Colorectal Cancer in the Bevacizumab Era: A Population-based Analysis
- (2011) Daniel J. Renouf et al. Clinical Colorectal Cancer
- Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study
- (2010) Niall C. Tebbutt et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III Study
- (2010) G.P. Stathopoulos et al. ONCOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search